This is consistent with a model where the accumulation of the enzymatically inactive p.I148M inhibits PNPLA2, leading to liver disease, whereas higher levels of wild‐type enzymatically active PNPLA3 may even be protective. The gene discussed is PNPLA3; the disease is liver disorder.